David Bumcrot

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Josh Mandel-Brehm, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Bumcrot:

Company Role Class Num Shares Value Price $ Report Date Ownership
Camp4 Therapeutics Corp Chief Scientific Officer Common Stock 61,741 10 Oct 2024 Direct
Camp4 Therapeutics Corp Chief Scientific Officer Stock Option (Right to Buy) 45,000 01 Apr 2025 Direct

Insider Reports Filed by David Bumcrot

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CAMP Camp4 Therapeutics Corp 01 Apr 2025 1 $0 4 Chief Scientific Officer 03 Apr 2025, 16:09
CAMP Camp4 Therapeutics Corp 10 Oct 2024 0 $0 3 Chief Scientific Officer 10 Oct 2024, 21:03